Thiogenesis Therapeutics, Corp.
TTI.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 648.90K | 1.18M | 2.51M | 1.35M | 2.10M |
| Total Receivables | 18.90K | 56.00K | 48.90K | 35.60K | 39.80K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 71.70K | 89.10K | 39.40K | 35.50K | 42.70K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 739.50K | 1.32M | 2.60M | 1.42M | 2.18M |
|
|
|||||
| Total Current Assets | 739.50K | 1.32M | 2.60M | 1.42M | 2.18M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 739.50K | 1.32M | 2.60M | 1.42M | 2.18M |
|
|
|||||
| Total Accounts Payable | 895.90K | 904.80K | 1.05M | 1.09M | 679.30K |
| Total Accrued Expenses | 6.30K | -- | 6.10K | -- | 12.00K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 902.20K | 904.80K | 1.06M | 1.09M | 691.30K |
|
|
|||||
| Total Current Liabilities | 902.20K | 904.80K | 1.06M | 1.09M | 691.30K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 902.20K | 904.80K | 1.06M | 1.09M | 691.30K |
|
|
|||||
| Common Stock & APIC | 14.31M | 14.53M | 14.30M | 11.89M | 11.28M |
| Retained Earnings | -16.25M | -15.83M | -14.34M | -12.90M | -10.92M |
| Treasury Stock & Other | 1.78M | 1.72M | 1.59M | 1.35M | 1.13M |
| Total Common Equity | -162.70K | 418.90K | 1.55M | 335.00K | 1.49M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -162.70K | 418.90K | 1.55M | 335.00K | 1.49M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -162.70K | 418.90K | 1.55M | 335.00K | 1.49M |
|
|
|||||